Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
about
Training to recognise the early signs of recurrence in schizophreniaThe 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statementsMethodological issues in negative symptom trialsWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.The therapeutic effectiveness of risperidone on negative symptoms of schizophrenia in comparison with haloperidol: a randomized clinical trial.Paliperidone: the evidence of its therapeutic value in schizophrenia.Do negative symptoms of schizophrenia change over time? A meta-analysis of longitudinal data.Novel antipsychotics in the long-term treatment of schizophrenia.Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychoticsTwo-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs: retrospective cohort study.Psychosocial treatments to promote functional recovery in schizophreniaOptimizing outcomes in schizophrenia: long-acting depots and long-term treatment.Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence.Clinical factors related to schizophrenia relapse.Long-Term Aripiprazole in Youth With Developmental Disabilities Including AutismPredictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study.Antipsychotic agents: efficacy and safety in schizophreniaShort-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.Effectiveness of paliperidone extended-release for patients with schizophrenia: focus on subjective improvement.Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study.Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis
P2860
Q24200966-CDADD229-8B62-42D6-AA14-40402E5D6AB6Q33566124-6AAC9C46-3B97-4990-815E-D0C4C4BEFE22Q33804836-3225D192-2BEE-4CB4-89F3-AF02C0A28923Q34315836-1145FF5E-F7EE-4775-BF8B-85174B39C3D5Q34367950-FC744AAD-A613-4EE6-B02C-FF2213B69AD1Q34449894-C0A45A5A-AF5B-409E-B958-2265C612AC1DQ35450483-B9CEDDF0-5DA0-4D4E-B881-0B6A1A93F7DAQ35719339-23BDF8FC-68C9-4E73-BC90-261B8947A70FQ35873789-B8EA0FA2-F3F8-4F42-A6E3-93A6D9093C0FQ36609365-27DBA27B-3470-4F2D-8D30-2B83450A9332Q37137030-8F396898-2FEA-4CF6-B5C2-A8CBEAAD9E23Q38086645-21BF6F1F-2BA0-4B63-9415-D5526DC9B987Q38244017-8671012F-20F3-46AF-BF9C-CBEE04231904Q38799868-5F3FB653-0E3A-4DC7-BB4C-FB1FEF877CF9Q38977828-CE46BE3C-3934-4081-B8E6-EAF0A7673193Q39821093-698B564A-EC55-4439-BCFB-A49E0237A348Q41957512-65AAB9F3-E217-447A-B42A-9A1BE21A3B96Q46604957-E682E0C9-4CC3-494E-8ECC-FF863A845D82Q48193359-B8DE0A9B-DCCC-4E74-B20E-F528FB444FDDQ51811285-1B83E1D5-77C2-45DC-94FD-6CE360FDD743Q58760344-C1227833-2925-4E6B-8CCF-9D3ACC29B493
P2860
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@en
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@nl
type
label
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@en
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@nl
prefLabel
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@en
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@nl
P2093
P1476
Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes.
@en
P2093
Clifford Widmark
Donna A Wirshing
Doreen Ross
Karen E Blair
Robert P Liberman
Shirley M Glynn
Stephen R Marder
William C Wirshing
P304
P356
10.1176/APPI.AJP.160.8.1405
P407
P577
2003-08-01T00:00:00Z